These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3928704)

  • 41. Cryoprecipitate shortens the bleeding time and reduces bleeding complications in patients with uremia.
    Jubelirer SJ; Janson PA; Weinstein MJ; Deykin D
    Trans Assoc Am Physicians; 1980; 93():182-91. PubMed ID: 6787774
    [No Abstract]   [Full Text] [Related]  

  • 42. The effect of desmopressin on massive gastrointestinal bleeding in hereditary telangiectasia unresponsive to treatment with cryoprecipitate.
    Quitt M; Froom P; Veisler A; Falber V; Sova J; Aghai E
    Arch Intern Med; 1990 Aug; 150(8):1744-6. PubMed ID: 2116786
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Uremic bleeding.
    Deykin D
    Kidney Int; 1983 Nov; 24(5):698-705. PubMed ID: 6363800
    [No Abstract]   [Full Text] [Related]  

  • 44. [Uremic polyneuropathy. Case studies].
    Fierro B; Fradà G; Li Vecchi M; Raimondo D
    Arch Sci Med (Torino); 1981; 138(4):609-14. PubMed ID: 7340740
    [No Abstract]   [Full Text] [Related]  

  • 45. Bleeding in uremia.
    Rabiner SF
    Med Clin North Am; 1972 Jan; 56(1):221-33. PubMed ID: 4550291
    [No Abstract]   [Full Text] [Related]  

  • 46. Uremic bleeding.
    Rabiner SF
    Prog Hemost Thromb; 1972; 1():233-50. PubMed ID: 4569724
    [No Abstract]   [Full Text] [Related]  

  • 47. Treatment of the bleeding tendency in uremia with cryoprecipitate.
    Janson PA; Jubelirer SJ; Weinstein MJ; Deykin D
    N Engl J Med; 1980 Dec; 303(23):1318-22. PubMed ID: 6776402
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: reduction in blood product usage with desmopressin.
    Czer LS; Bateman TM; Gray RJ; Raymond M; Stewart ME; Lee S; Goldfinger D; Chaux A; Matloff JM
    J Am Coll Cardiol; 1987 May; 9(5):1139-47. PubMed ID: 3571753
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding.
    Levy JH; Szlam F; Tanaka KA; Sniecienski RM
    Anesth Analg; 2012 Feb; 114(2):261-74. PubMed ID: 21965371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of 1-deamino-8-D-arginine vasopressin (DDAVP) on bleeding time in uremic patients].
    Alarcón F; Mezzano D; Vial S; Pereira J
    Rev Med Chil; 1985 Aug; 113(8):763-8. PubMed ID: 3938558
    [No Abstract]   [Full Text] [Related]  

  • 51. Shortening of bleeding time after intranasal administration of 1-deamino-8-D-arginine vasopressin to patients with chronic uremia.
    Rydzewski A; Rowiński M; Myśliwiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):823-30. PubMed ID: 2436997
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acquired hemophilia.
    Bouvry P; Recloux P
    Haematologica; 1994; 79(6):550-6. PubMed ID: 7896216
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass.
    de Prost D; Barbier-Boehm G; Hazebroucq J; Ibrahim H; Bielsky MC; Hvass U; Lacombe C; Français JL; Desmonts JM
    Thromb Haemost; 1992 Aug; 68(2):106-10. PubMed ID: 1412152
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Life-threatening bleeding from refractory acquired FVIII inhibitor successfully treated with rituximab.
    Jy W; Gagliano-DeCesare T; Kett DH; Horstman LL; Jimenez JJ; Ruiz-Dayao Z; Santos ES; Ahn YS
    Acta Haematol; 2003; 109(4):206-8. PubMed ID: 12853696
    [No Abstract]   [Full Text] [Related]  

  • 55. Hyponatremia may be an under-recognized complication after desmopressin to reduce uremic bleeding in kidney biopsy.
    Lim CC; Chawla M; Siow B; Choo JCJ; Lee PH; Foo M; Tan CS
    Nephrology (Carlton); 2019 Jun; 24(6):674. PubMed ID: 31006950
    [No Abstract]   [Full Text] [Related]  

  • 56. Study on mechanisms of a haemostatic effect of 1 deamino-8-D-arginine vasopressin (desmopressin) in uraemic patients.
    Malyszko J; Pietraszek M; Buczko W; Mysliwiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(2):319-24. PubMed ID: 1697836
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Coagulopathy in multiple trauma: new aspects of therapy].
    Grottke O; Henzler D; Spahn DR; Rossaint R
    Anaesthesist; 2007 Jan; 56(1):95-106; quiz 107-8. PubMed ID: 17219186
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Unconventional methods of the treatment of blood coagulation disorders in hemophilia patients].
    Kowalewski J
    Acta Haematol Pol; 1987; 18(1-2):127-30. PubMed ID: 3124484
    [No Abstract]   [Full Text] [Related]  

  • 59. [Indications for the use of platelets, plasma and anti-hemorrhagic drugs].
    Mateo J; Muñiz-Díaz E; Fontcuberta J; Madoz P
    Rev Esp Anestesiol Reanim; 1992; 39(6):355-61. PubMed ID: 1293653
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of hemostatic activity of desamino-D-arginine vasopressin (DDAVP) in uremic rats.
    Kaufman S; Stewart M; Gordon PA
    Thromb Res; 1994 Jan; 73(1):53-9. PubMed ID: 8178313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.